Twelfth EDCTP Forum

15–20 Jun 2025 | Kigali, Rwanda

Christian Nsanzabana

Group Leader

Swiss Tropical and Public Health Institute

Allschwil, Switzerland

3 profile visits

My name is Christian Nsanzabana, and I'I lead the Malaria Genotyping Group at the Swiss Tropical and Public Health Institute (Swiss TPH).

My organisation

Swiss TPH - Excellence in Global Health The Swiss Tropical and Public Health Institute (Swiss TPH) is a world-leading institute in global health with a particular focus on low- and middle-income countries. Research, education and services By uniquely combining research, education and services, we aim to improve the health and well-being of people through a better understanding of disease and health systems and by acting on this knowledge. From science to impact Our translational approach, from innovation and validation to application, enables us to bring novel diagnostics, drugs and vaccines directly to people, communities, policy and decision makers. Throughout, we pursue a spirit of partnership and strive for sustainable impact in over 130 countries. Broad expertise 950 staff and students from 95 nations work at Swiss TPH focusing on climate change, environment and health, infectious and non-communicable diseases, societal and cultural context, and health systems and policies. Our expertise spans from the bench to the field, from basic to operational, from molecular to spatial, and from genes to health systems. We treasure partnership, constantly go the extra mile and contribute to the Sustainable Development Goals.
Read more

About me

Dr Christian Nsanzabana is a biologist by training, and has more than 16 years’ postdoctoral experience in malaria research going from basic to translational and implementation research. He completed his PhD in Molecular Epidemiology at the University of Neuchâtel in 2008, followed by one year at the Centre Suisse de Recherches Scientifiques en Côte d’Ivoire (CSRS), overseeing different projects assessing the efficacy of new products for malaria vector control. Between 2010 and 2015, he was a postdoctoral fellow at the University of California San Francisco (UCSF), and University of Oxford, where he worked on mode of actions and mechanisms of resistance of antimalarial drugs, and meta-analyses to assess the factors affecting efficacy drugs, respectively. He further worked with the Foundation for Innovative New Diagnostics (FIND) on the quality control of malaria rapid diagnostic test. He is currently a Group Leader at Swiss TPH, where he leads the Malaria Genotyping Group.

Social media

Skills

  • Molecular Biology
  • Genomics
  • molecular epidemiology

Interests

  • Antimalarial Drug Resistance
  • antimalarial drug efficacy
  • genomic epidemiology